Precocious Puberty Clinical Trials

Find Precocious Puberty Clinical Trials Near You

INSL3 as an Early Marker of Pubertal Activation: Evaluation of Its Potential Role as a New Biomarker in the Diagnosis of Central Precocious Puberty and Delayed Puberty.

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

This is an observational study in children up to 16 years old who are suspected of having central precocious puberty or delayed puberty. The main questions it aims to answer are: * Can the level of insulin-like peptide 3 (INSL3) predict if a child's puberty has truly started? * Can this marker help reduce the need for more complex and invasive tests? Participants will: * Give one extra blood sample just before starting the standard gonadotropin-releasing hormone (GnRH) stimulation test (during the baseline blood draw). * Have this extra sample used to measure the INSL3 hormone. * Complete the rest of the GnRH test as prescribed by their doctor. Researchers will compare the INSL3 hormone levels in children who have a positive GnRH test to those who have a negative test. This will help researchers learn if INSL3 can be used as a new, simple tool to diagnose early or delayed puberty.

Eligibility
Participation Requirements
Sex: All
Maximum Age: 18
Healthy Volunteers: f
View:

• Age between 0 and 16 years at the time of enrollment.

• Males with suspected Central Precocious Puberty (CPP), defined by a testicular volume ≥4 mL before 9 years of age.

• Females with suspected CPP, defined by the onset of thelarche before 8 years of age.

• Males with suspected Delayed Puberty (DP), defined by testicular volume \<4 mL by 14 years of age.

• Females with suspected DP, defined by the absence of thelarche by 13 years of age.

• Written informed consent for study participation and personal data processing provided by the parents/legal guardians, with the assent of the participating minor.

Locations
Other Locations
Italy
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Bologna 40138
RECRUITING
Bologna
Contact Information
Primary
Federico Baronio, MD, PhD
federico.baronio@aosp.bo.it
00390512144816
Time Frame
Start Date: 2026-10-02
Estimated Completion Date: 2029-01-01
Participants
Target number of participants: 100
Treatments
Suspected Central Precocious Puberty (CPP)
Pediatric patients (males under 9 years, females under 8 years) with clinical signs of early pubertal onset, undergoing a standard GnRH stimulation test.
Suspected Delayed Puberty (DP)
Pediatric patients (males 14 years and older, females 13 years and older) with absent signs of puberty, undergoing a standard GnRH stimulation test.
Related Therapeutic Areas
Sponsors
Leads: IRCCS Azienda Ospedaliero-Universitaria di Bologna

This content was sourced from clinicaltrials.gov